Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $10.9 million.

  • Corcept Therapeutics' Change in Account Payables rose 178274.27% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 65617.49%. This contributed to the annual value of -$2.2 million for FY2024, which is 13890.62% down from last year.
  • As of Q3 2025, Corcept Therapeutics' Change in Account Payables stood at $10.9 million, which was up 178274.27% from -$4.8 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Change in Account Payables registered a high of $12.9 million during Q1 2025, and its lowest value of -$4.9 million during Q1 2024.
  • For the 5-year period, Corcept Therapeutics' Change in Account Payables averaged around $1.3 million, with its median value being -$165000.0 (2022).
  • In the last 5 years, Corcept Therapeutics' Change in Account Payables tumbled by 111026.62% in 2021 and then surged by 530303.03% in 2023.
  • Corcept Therapeutics' Change in Account Payables (Quarter) stood at $364000.0 in 2021, then soared by 1065.38% to $4.2 million in 2022, then tumbled by 76.54% to $995000.0 in 2023, then crashed by 435.08% to -$3.3 million in 2024, then soared by 427.56% to $10.9 million in 2025.
  • Its Change in Account Payables stands at $10.9 million for Q3 2025, versus -$4.8 million for Q2 2025 and $12.9 million for Q1 2025.